All Stories

  1. Avelumab and other recent advances in Merkel cell carcinoma

    Article • Future Oncology, December 2017, Future Medicine

    Dr Howard L Kaufman

  2. Immune evasion mechanisms and immune checkpoint inhibition in advanced merkel cell carcinoma

    Article • OncoImmunology, August 2017, Taylor & Francis

    Dr Howard L Kaufman

  3. Systematic literature review of efficacy, safety and tolerability outcomes of chemotherapy regimens in patients with metastatic Merkel cell carcinoma

    Article • Future Oncology, June 2017, Future Medicine

    Dr Howard L Kaufman

  4. Critical analysis of an oncolytic herpesvirus encoding granulocyte-macrophage colony stimulating factor for the treatment of malignant melanoma

    Article • Oncolytic Virotherapy, January 2014, Taylor & Francis

    Dr Howard L Kaufman

  5. Oncolytic virus therapy for cancer

    Article • Oncolytic Virotherapy, September 2013, Taylor & Francis

    Dr Howard L Kaufman

  6. Cytokines in the Treatment of Cancer

    Article • September 2012, Springer Science + Business Media

    Dr Howard L Kaufman

  7. Modulating the Tumor Microenvironment

    Article • November 2011, Springer Science + Business Media

    Dr Howard L Kaufman

  8. An update on TroVax® for the treatment of progressive castration-resistant prostate cancer

    Article • OncoTargets and Therapy, May 2011, Taylor & Francis

    Dr Howard L Kaufman

  9. Molecular Targeting in Oncology

    Article • January 2008, Springer Science + Business Media

    Dr Howard L Kaufman

  10. General Principles of Tumor Immunotherapy

    Article • January 2007, Springer Science + Business Media

    Dr Howard L Kaufman

  11. DNA Vaccines for Cancer Immunotherapy

    Article • January 2006, Springer Science + Business Media

    Dr Howard L Kaufman

  12. Columbia University

    Article • The Lancet Oncology, October 2005, Elsevier

    Dr Howard L Kaufman

  13. DNA Vaccines

    Article • January 2004, Springer Science + Business Media

    Dr Howard L Kaufman

  14. The role of poxviruses in tumor immunotherapy

    Article • Surgery, November 2003, Elsevier

    Dr Howard L Kaufman